More than one billion people worldwide suffer from obstructive sleep apnea, and Oral Appliance Therapy (OAT) is a growing treatment option for many healthcare providers. Traditionally, practitioners have diagnosed or assessed a patient’s sleep disordered breathing issues, including OSA, using the apnea hypopnea index (AHI). During this webinar, Dr. John Remmers will discuss the factors that contribute to AHI and explain a better way to predict outcomes exists. In addition, you’ll learn how implementing a practical, evidence-based treatment planning solution will increase OAT’s efficacy and improve patient care.
Wednesday, October 7
6:00 pm Eastern
Dr. John Remmers
Dr. John Remmers is the Chief Medical Officer and Co-founder of Zephyr Sleep Technologies. He is a recognized physiologist, pioneer, and innovator in sleep medicine. As a world-renowned expert in the field of snoring and obstructive sleep apnea, Dr. Remmers was the first researcher to elucidate the pathogenesis of sleep apnea and to demonstrate that sleep apnea is caused by the narrowing of the pharynx. Today, his research interests relate to the neurobiology of respiratory rhythmogenesis, chemoreception, and the pathophysiology of the control of breathing.